Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127574041 | 12757404 | 1 | I | 20160908 | 20160919 | 20160919 | PER | US-JNJFOC-20160909600 | JOHNSON AND JOHNSON | 70.00 | YR | E | M | Y | 61.69000 | KG | 20160919 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127574041 | 12757404 | 1 | PS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 1 TABLET DAILY | N | 464077 | 19835 | 10 | MG | TABLET | QD | ||||
| 127574041 | 12757404 | 2 | SS | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 1 TABLET DAILY | N | 464077 | 19835 | 10 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127574041 | 12757404 | 1 | Sinus disorder |
| 127574041 | 12757404 | 2 | Rhinorrhoea |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127574041 | 12757404 | Drug ineffective | |
| 127574041 | 12757404 | Drug ineffective for unapproved indication | |
| 127574041 | 12757404 | Off label use | |
| 127574041 | 12757404 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127574041 | 12757404 | 1 | 20160907 | 0 | ||
| 127574041 | 12757404 | 2 | 20160907 | 0 |